Volition veterinary presents two posters at the 2021 veterinary cancer society conference

Positive data show nu.q® can be used to monitor for disease response and progression including remission monitoring in cancer bearing dogs. paves the way for second nu.q® vet product launch planned for 2022.

VNRX Ratings Summary

VNRX Quant Ranking